Squarepoint
GILD icon

Squarepoint’s Gilead Sciences GILD Stock Holding History

Squarepoint’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.8M Sell
56,000
-42,400
-43% -$5.94M 0.01% 1214
2025
Q4 		$12.1M Sell
98,400
-13,300
-12% -$1.62M 0.01% 992
2025
Q3 		$12.4M Sell
111,700
-86,900
-44% -$9.88M 0.01% 971
2025
Q2 		$22M Sell
198,600
-64,900
-25% -$6.91M 0.02% 724
2025
Q1 		$29.5M Buy
263,500
+157,000
+147% +$16.2M 0.04% 524
2024
Q4 		$9.84M Sell
106,500
-66,200
-38% -$5.96M 0.01% 1162
2024
Q3 		$14.5M Buy
172,700
+38,700
+29% +$2.95M 0.02% 752
2024
Q2 		$9.19M Buy
134,000
+43,900
+49% +$2.93M 0.02% 985
2024
Q1 		$6.6M Buy
90,100
+56,300
+167% +$4.33M 0.01% 1258
2023
Q4 		$2.74M Buy
33,800
+17,700
+110% +$1.38M 0.01% 1794
2023
Q3 		$1.21M Sell
16,100
-8,900
-36% -$685K ﹤0.01% 2185
2023
Q2 		$1.93M Sell
25,000
-19,800
-44% -$1.58M 0.01% 1679
2023
Q1 		$3.72M Buy
44,800
+34,600
+339% +$2.87M 0.02% 1048
2022
Q4 		$876K Buy
10,200
+800
+9% +$63.4K ﹤0.01% 1909
2022
Q3 		$580K Hold
9,400
– – ﹤0.01% 2131
2022
Q2 		$581K Sell
9,400
-63,800
-87% -$3.95M ﹤0.01% 1926
2022
Q1 		$4.35M Sell
73,200
-360,400
-83% -$23M 0.02% 787
2021
Q4 		$31.5M Buy
433,600
+13,300
+3% +$916K 0.08% 210
2021
Q3 		$29.4M Buy
420,300
+106,400
+34% +$7.48M 0.08% 223
2021
Q2 		$21.6M Sell
313,900
-218,000
-41% -$14.6M 0.08% 222
2021
Q1 		$34.4M Buy
+531,900
New +$34.3M 0.2% 96

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Squarepoint's GILD Position: Q1 2026 in Review

Squarepoint reduced its Gilead Sciences (GILD) stake by 15% in Q1 2026, selling an estimated $5.19M and leaving 206,207 shares worth $28.7M. The position accounts for 0.03% of the portfolio, ranked #531.

Squarepoint first reported a position in GILD in Q4 2014 and has held it in 38 quarters since. The position peaked at $129M in Q2 2024. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Squarepoint held 206,207 shares of Gilead Sciences worth $28.7M as of Q1 2026.
  • Squarepoint sold 37,079 Gilead Sciences shares in Q1 2026, an estimated $5.19M.
  • Gilead Sciences made up 0.03% of Squarepoint's portfolio in Q1 2026, its #531 holding.
  • Squarepoint first reported a position in Gilead Sciences in Q4 2014 and has held it in 38 quarters since.
  • Squarepoint's Gilead Sciences position peaked at $129M in Q2 2024.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.